Paroxysmal nocturnal haemoglobinuria | Nature Reviews Disease Primers
How I treat paroxysmal nocturnal hemoglobinuria - ScienceDirect
JCM | Free Full-Text | Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties | HTML
Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study - Thrombosis Research
Algorithm of the clinical management of paroxysmal nocturnal... | Download Scientific Diagram
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria - ScienceDirect
PNH Testing, Symptoms & Treatment | Ultomiris.com
The ITP Support Association - Clinical Trials
Ultomiris Efficacy | PNH Treatment and Symptoms | Ultomiris.com
Phase II and III PNH clinical trials overview. | Download Scientific Diagram
All About Paroxysmal Nocturnal Hemoglobinuria (PNH) | Everyday Health
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial - The Lancet Haematology
Recent advances in the pathogenesis and treatment... | F1000Research
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia | Leukemia
A novel patient-reported outcome instrument assessing the symptoms of paroxysmal nocturnal hemoglobinuria, the PNH-SQ | Journal of Patient-Reported Outcomes | Full Text
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry | Haematologica
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review - Devalet - 2015 - European Journal of Haematology - Wiley Online Library
Paroxysmal Nocturnal Hemoglobinuria Clinical Trials
The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. - Abstract - Europe PMC
PNH Foundation - PNH: ALPHA Study: Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH) https://www.aamds.org/treatments/clinical-trials/alpha ...
Current Opinions on the Clinical Utility of Ravulizumab for the Treatm | TCRM
References in Eculizumab for paroxysmal nocturnal haemoglobinuria - The Lancet
Akari's paroxysmal nocturnal hemoglobinuria asset has six-point fall
Paroxysmal Nocturnal Hemoglobinuria Global Clinical Trials Review, H1, 2018
Clinical Indications for PNH Testing | Download Scientific Diagram
